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O B J E C T I V E S The purpose of this study was to determine the prognostic utility of dobutamine
cardiac magnetic resonance (DCMR) stress test results in women.
B A C KG ROUND To date, the preponderance of studies reporting the utility of DCMR stress results
for predicting cardiac prognosis have been performed in men. We sought to determine the utility of
DCMR results for predicting cardiac prognosis in women.
METHOD S Two hundred sixty-six consecutively referred women underwent DCMR in which left
ventricular wall motion (LVWM) was assessed at rest and after intravenous dobutamine and atropine.
Inducible LVWM abnormalities were identiﬁed during testing. Women were contacted to determine the
post-DCMR occurrence of a cardiac event. All events were substantiated according to deﬁned criteria
and then were veriﬁed after a thorough medical record review by individuals blinded to testing data.
R E S U L T S Women were contacted an average of 6.2 1.6 (median 6.2, range 0.8 to 10.4) years after
DCMR; 27% of the women experienced an inducible LVWM abnormality during testing. In those with and
without inducible LVWM abnormalities, the proportion of women with cardiac events were 63% versus
30%, respectively, (hazard ratio [HR]: 2.7; 95% conﬁdence interval [CI]: 1.8 to 4.3 for the presence of
inducible LVWM abnormalities p  0.0001). The proportion of women with myocardial infarction (MI)
and cardiac death were 33.3% and 7.5%, respectively. This resulted in a HR for MI and cardiac death of
4.1 (95% CI: 2.2 to 9.4) for those with versus those without inducible LVWM abnormalities; p  0.0001.
A subgroup analysis was performed in women without a history of coronary artery disease and in those
with LVWM abnormalities, DCMR remained an adverse predictor of cardiac events (HR: 4.0, 95% CI: 1.8
to 9.0, p  0.003).
CONC L U S I O N S Inducible LVWM abnormalities during DCMR predict cardiac death and MI in
women. Similar to men, these results indicate that DCMR is a valuable noninvasive stress imaging
modality for identifying cardiac risk in women with known or suspected ischemic heart disease. (J Am
Coll Cardiol Img 2009;2:299–307) © 2009 by the American College of Cardiology Foundation
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300obutamine cardiac magnetic resonance
(DCMR) has been used to identify cardiac
risk in individuals with or suspected of
having coronary artery disease (1,2). To
ate, the majority of participants in these previous
CMR studies of prognosis have been men (1,2).
ecently, the diagnostic utility of DCMR for iden-
ifying flow-limiting coronary artery stenoses in
omen was shown to be high (3). At present,
owever, it is uncertain whether the results of
CMR can be used to predict cardiac events in
omen, particularly those that are difficult to risk
tratify with other forms of noninvasive imaging.
ccordingly, we performed this study to determine
he prognostic utility of DCMR results for forecast-
ng future cardiac events in women suspected of
aving or known to have acquired coronary arterio-
clerosis.
M E T H O D S
Study population and design. The Institu-
tional Review Board at the Wake Forest
University School of Medicine approved
this study, and all participants provided
witnessed informed consent. Patients with
contraindications to DCMR (implanted
pacemakers, defibrillators, or intracranial
metal) were excluded from enrollment.
The study population consisted of 266
consecutive women that had undergone
high-dose dobutamine and atropine stress
testing between 1997 and 2004, secondary
to 6 of 17 segments not well observed
ith second harmonics transthoracic echocardiog-
aphy with or without microbubble contrast. The
tudy was designed as a prospective cohort analysis
n which cardiac outcomes were determined after
omen received DCMR stress.
The DCMR procedure. As previously described,
DCMR stress images were collected on a Horizon
1.5-T whole-body imaging system (General Elec-
tric Medical Systems, Milwaukee, Wisconsin) by
the use of cine white blood gradient-echo imaging
(4). Images were viewed with the use of a software
program designed for display of dobutamine stress
magnetic resonance images in a multiwindow, syn-
chronized format (5). According to previously pub-
lished techniques (1–5), left ventricular wall motion
(LVWM) was assessed at rest and after intravenous
dobutamine and atropine administered to achieve
80% of the maximum predicted heart rate response
c
ion
llfor age. We identified LVWM throughout testing oacross myocardial segments identified by the Amer-
ican Heart Association as normal, hypokinetic,
akinetic, or dyskinetic (6). Akinetic segments that
exhibited a dyskinetic response to stress testing were
not included in our analysis. As previously de-
scribed, the resting left ventricular ejection fraction
(LVEF) was measured by the use of a biplane
area–length technique (7). Myocardial segments
were identified by the use of an 18-segment model
previously described (1). Inducible LVWM abnor-
malities were defined as deterioration of LVWM
during infusion (1,2,4,5,8).
Participants’ routine use of medications, including
-receptor antagonists, was not altered before testing.
An occurrence of previous Q-wave myocardial infarc-
tion (MI), previous coronary artery revascularization,
and risk factors for coronary arteriosclerosis, including
the treatment or presence of hypertension (blood
pressure 140/90 mm Hg), a total serum cholesterol
alue 6.4 mmol/l, a fasting glucose measuring 7.8
mol/l, a history of chronic obstructive pulmonary
isease, and a history of smoking were recorded at the
ime of DCMR testing.
Outcomes. Personnel blinded to the study design or
tress testing results contacted each subject (or, if
eceased, an immediate family member) to determine
hether cardiac events had occurred since their
CMR test. The date of last contact was recorded.
ll events were confirmed by review of the partici-
ant’s medical records. Hard events were defined as
I (angina of 20 min duration and either 1-mm
T-segment elevation in 2 contiguous electrocardio-
raphic [ECG] leads, or a rise in troponin and
reatine kinase level and its myocardial band fraction
xceeding the 99th percentile) (9), or cardiac death
death during a hospital admission for acute coronary
yndrome, significant cardiac arrhythmia, or refractory
ongestive heart failure). Other events (termed any
vents) included hard events, all-cause mortality, cor-
nary arterial revascularization, unstable angina or
ongestive heart failure warranting hospital admission.
hen available, ECG, enzymatic, or autopsy data
ere used to substantiate cardiac mortality. In the case
f 2 simultaneous cardiac events, the worst event was
elected for use in follow-up (cardiac death  MI 
revascularization  unstable angina or congestive
heart failure).
Statistical analysis. Patients were categorized accord-
ng to the presence, extent, and location of inducible
VWM abnormalities during pharmacologic infu-
ion. All grouped data were expressed as mean 
tandard deviation. The association between the riskA B B R E V I A T I O N S
A N D A C R O N YM S
CI confidence interval
DCMR dobutamine cardia
magnetic resonance
DSE dobutamine stress
chocardiography
R hazard ratio
VEF left ventricular eject
raction
VWM left ventricular wa
motionf future cardiac events and individual patient factors
p
a
d
m
t
C
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301was estimated and tested for significance with the Cox
proportional hazards model. Univariable patient fac-
tors that were tested for their potential association
with risk of future cardiac events were selected based
upon previous association with cardiovascular events.
These potential cardiac risk factors were included in
the multivariable Cox proportional hazards regression
models if they showed a univariable association with p
 0.20. Collinearity was examined, and none of the
independent variables had a pairwise correlation
0.50. The increased or decreased risk of future
cardiovascular events due to the presence or absence of
a given variable was expressed by a hazard ratio (HR)
with a corresponding 95% confidence interval (CI).
Variables were considered significant if the null hy-
pothesis of no contribution could be rejected at the 5%
level of significance probability value of 0.05. The
reasonableness of assuming a proportional hazard
model for each univariable and multivariable model
was assessed using the test for proportional hazards
based on Schoenfeld residuals; in no cases did any of
the tests give p 0.30 (10,11). The probability of the
presence or absence of cardiac events as a function of
follow-up duration was estimated by the Kaplan-
Meier method and compared between groups by use
of the log-rank test.
R E S U L T S
Contact was made with all participants (100% partic-
ipant follow-up) at a mean of 6.2  1.6 (median 6.2,
range 0.8 to 10.4) years after performance of the
DCMR procedure. The mean age of the women at
the time of DCMR testing was 63 12 years. Of the
266 participants, 9 underwent coronary arterial revas-
cularization (coronary artery bypass or percutaneous
intervention) within 60 days of their DCMR stress
test. To exclude the possibility that test results influ-
enced or biased decision making or that immediate
revascularization prevented or promoted subsequent
hard events, we excluded these 9 subjects from anal-
ysis. Thirty-six (13.5%) women did not achieve max-
imal heart rate response as a result of the prescribed
use of rate limiting calcium antagonists or beta block-
ers. Because previous studies have identified a reduced
sensitivity and specificity of stress test results for
identifying inducible LVWM abnormalities at heart
rate responses of 80% to 85% of the maximum
redicted for age (12,13), these individuals’ outcome
nalyses were assessed separately.
Baseline data on the remaining 221 participants are
isplayed in Table 1. As shown, the age and body
ass index (BMI) of the 2 groups of participants weresimilar. The group with inducible LVWM abnormal-
ities more frequently experienced previous coronary
artery revascularization procedures, diabetes, and a
mildly reduced LVEF at the time of testing. Hemo-
dynamic data from the participants are shown in
Table 2.
There were 149 total cardiac events among 89
participants during the course of the study; 36 of these
were hard events. Of the hard events, there were 15
cardiac deaths among 60 participants with inducible
LVWM abnormalities, and 6 among the 161 partic-
ipants without inducible LVWM abnormalities. The
mean follow-up for event free patients was 6.1 years
(25th percentile: 4.8 years, 75th percentile: 7.4 years),
nearly the same for women experiencing a cardiac
event. The occurrences of all cardiac events are dis-
played in Table 1. Four patients experienced a non-
fatal MI in a separate hospitalization from their
cardiac death. As shown, deterioration in LVWM
predicted a future increase in the occurrence of cardiac
death, MI, coronary artery revascularization, and un-
stable angina warranting hospitalization.
Sixty of the 221 women (27%) experienced induc-
ible LVWM abnormalities during cardiac testing.
The overall proportion of women with cardiac events
in those with and without inducible LVWM abnor-
malities were 63.0% and 30.0%, respectively (p 
0.0001), and the proportion of women with hard
events was 33.3% and 7.5%, respectively (p 0.0001).
A Kaplan-Meier analysis of the overall event rate and
the hard event rate, in those with and without induc-
ible LVWM abnormalities, is shown in Figure 1.
Figure 2 displays the HRs of cardiac events in isola-
tion (univariable) and after accounting for risk factors
for coronary arteriosclerosis or cardiac events predicted
in the univariable analysis (multivariable analysis).
One-hundred ten women in our population
without a history of coronary artery disease (history
of MI or previous coronary revascularization) un-
derwent stress testing. The 5-year event rate for all
cardiac events in women with inducible LVWM
abnormalities but without coronary disease was
lower, 27.6% versus 46.1%, than those with coro-
nary atherosclerosis (p 0.001). In women without
known coronary atherosclerosis, LVWM abnor-
malities during testing remained an adverse predic-
tor of any cardiac event (HR: 4.0, 95% CI: 1.8 to
9.0, p  0.003), and trended towards identifying
hose at risk of a future hard event (HR: 2.7, 95%
I: 0.7 to 11.6, p  0.14).
We examined the relationship between the number
of segments that experienced deterioration in LVWM
and future events. Overall, 3,970 segments were as-
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302Table 1. Demographic Data and Summary of Events
All Inducible LVWMA No Inducible LVWMA p Value
Patient characteristics
Patients, % n  221 n  60 (27) n  161 (73)
Age (yrs) 63 12 62 12 63 12 0.56
Weight, kg 189 48 87 20 85 23 0.7
BMI, kg/m2 33 8 34 8 32 9 0.18
LVEF, % 59 11 51 12 62 10 0.0001
Historical information (%)
Previous Q-wave MI 62 (28) 22 (37) 40 (25) 0.08
Previous revascularization 81 (37) 32 (53) 49 (30) 0.001
Previous PCI 55 (25) 24 (40) 30 (19) 0.001
Previous CABG 42 (19) 16 (27) 26 (16) 0.08
Hypertension 162 (73) 49 (82) 113 (70) 0.087
Diabetes 84 (38) 30 (50) 54 (34) 0.025
Hyperlipidemia 127 (57) 38 (63) 89 (55) 0.28
Family history 115 (52) 31 (52) 84 (52) 0.95
Smoking 83 (38) 26 (43) 57 (35) 0.28
COPD/asthma 47 (21) 9 (15) 38 (24) 0.17
Congestive heart failure 25 (11) 11 (18) 14 (9) 0.044
Medications (%)
Digoxin 13 (6) 3 (5) 10 (6) 0.74
Diuretic 103 (47) 33 (55) 70 (43) 0.13
Beta-blocker 77 (35) 23 (38) 54 (34) 0.51
Calcium antagonist 48 (22) 18 (30) 30 (19) 0.069
Aspirin 110 (50) 34 (57) 76 (47) 0.21
Nitrate 66 (30) 27 (45) 39 (24) 0.0026
ACE inhibitor/ARB 62 (28) 26 (43) 36 (22) 0.002
Anticoagulation 18 (8) 4 (7) 14 (9) 0.63
Antilipid 86 (39) 24 (40) 62 (39) 0.84
Events (%)
Cardiac death 21 (10) 15 (25) 6 (4) 0.0001
MI 19 (11) 10 (17) 9 (6) 0.01
Revascularization 46 (21) 19 (32) 27 (16) 0.011
Unstable angina 46 (21) 22 (37) 24 (14) 0.001
Congestive heart failure 17 (8) 6 (10) 11 (6) 0.34
Values are expressed as n (%) unless otherwise indicated.
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; BMI  body mass index; CABG  coronary artery bypass grafting; COPD  chronic
obstructive pulmonary disease; LVEF  left ventricular ejection fraction; LVWMA  left ventricular wall motion abnormalities; MI  myocardial infarction; PCI 
percutaneous coronary intervention.Table 2. Hemodynamic Data
All Inducible LVWMA No Inducible LVWMA p Value
Resting HR (beats/min) 76 12 72 12 77 14 0.35
Peak HR (beats/min) 131 14 121 18 148 24 0.0001
% MPHRR 83 8 77 11 85 4 0.0001
Resting SBP (mm Hg) 142 23 137 23 145 22 0.058
Peak SBP (mm Hg) 146 26 140 30 148 24 0.052
Resting DBP (mm Hg) 79 14 75 16 81 13 0.002
Peak DBP (mm Hg) 74 15 72 17 75 14 0.15
Rest rate/pressure product 10,838 2,652 9,978 2,250 11,159 2,732 0.0035
Peak rate/pressure product 19,121 3,882 16,947 4,547 19,865 3,275 0.0001
DBP  diastolic blood pressure; HR  heart rate; MPHRR  maximum predicted heart rate response for age; SBP  systolic blood pressure; other abbreviation as
in Table 1.
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303sessed during testing. In regard to the number of
segments that experienced deterioration in LVWM,
the estimated proportion of women without a hard
event at 5 years was 64.2% versus 79.6%, respectively,
for those individuals experiencing deterioration in
LVWM in 1 or 2 segments versus3 segments. (p
0.20). Similarly, for individuals with inducible
LVWM abnormalities involving 1 coronary artery
territory (as defined by the American Heart Associa-
tion) (6), the estimated proportion of women without
a hard event at 5 years was 71.1% versus 73.3%,
respectively, in women with an inducible LVWM
Figure 1. Kaplan-Meier Survival Plots Indicating the Proportion
Women with inducible LVWM abnormalities are indicated by the re
indicated by the gold lines. As shown, those individuals without in
top; hard, bottom) compared with individuals with inducible LVWM
dial infarction.abnormality in 2 or 3 coronary territories (p  0.86).The 36 individuals that did not achieve a heart rate
response of 80% predictive for age without an induc-
ible LVWM abnormality averaged 58  10 years
(range 45 to 72 years) in age and exhibited a resting
LVEF of 58  14% (range 20% to 76%). Over 5
years, this group of individuals experienced 4 hard
events, of which 1 was a cardiac death; their 5-year
overall estimated percentage of women having a hard
event rate was 11%. This 5-year percentage was
similar to the 7% 5-year event percentage of hard
events in individuals without inducible LVWM ab-
normalities that achieved 80% predicated heart rate
omen Free From Cardiac Events Versus Time
es, and individuals without inducible LVWM abnormalities are
ble LVWM abnormalities experienced fewer cardiac events (any,
normalities. LVWM  left ventricular wall motion; MI  myocar-of W
d lin
duci
abresponse for age, and substantially lower than the
COPD  chronic obstr oti
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3045-year event percentage of 33% in individuals with
inducible LVWM abnormalities. The same women
experienced 13 total cardiac events (for an overall
percentage of events of 36%), which was similar to
individuals without inducible LVWM abnormalities
that achieved 80% predicted heart rate response for
age (29%), and not as elevated (5-year proportion of
those with events of 63%) as individuals with induc-
ible LVWM abnormalities.
D I S C U S S I O N
The results of this study indicate that in women poorly
suited for noninvasive imaging with dobutamine stress
echocardiography (DSE), the presence of DCMR-
inducible LVWM abnormalities forecasts a high rate
of cardiovascular events, including future MI and
cardiac death (Table 1). Second, there is a high
negative predictive value of DCMR wall motion stress
test results in women (Fig. 1). Women who obtain
80% predictive heart rate response for age during
pharmacologic stress without inducible LVWM ab-
and Multivariable Predictors for Cardiac Events
ariable analyses displaying hazard ratios  95% conﬁdence intervals
s risk factors for coronary arteriosclerosis and myocardial infarction.
tor of MI and cardiac death, and any cardiac event after accounting
uctive pulmonary disease; MI  myocardial infarction; WMA  wall mnormalities exhibit an event free survival of 1.2% peryear for MI and cardiac death for the 5 years after the
stress test. Third, the results of DCMR stress are
useful in determining cardiac risk in women after
accounting for known clinical predictors of adverse
cardiac risk (Fig. 2).
Despite the fact that more women than men die
annually of cardiac events related to coronary artery
disease, women are under reported in studies as-
sessing the prognostic utility of cardiovascular test-
ing methods (14). In addition, with transthoracic
echocardiography, due to poor acoustic windows, or
radionuclide scintigraphy, due to attenuation arti-
facts, it is often difficult to obtain adequate imaging
test results in women (15,16). Studies have demon-
strated a greater diagnostic accuracy of DCMR in
detection of LVWM abnormalities compared with
DSE (17), and there are several additional studies
that have highlighted the utility of DCMR stress to
forecast cardiac prognosis (1,2,12,18). To date,
however, there have been limited data on the
prognostic utility of DCMR for determining car-
xis) for developing MI or cardiac death (A), and any cardiac events
hown, a stress-induced left ventricular wall motion abnormality is
nown risk factors for cardiac events. BMI  body mass index;
on abnormalities.Figure 2. Univariable
Univariable and multiv (x-a
(B). This model include As s
an independent predic for kdiac prognosis in women with suspected coronary
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305artery disease (19). Given the need to identify
cardiac prognosis in women and the difficulty in
obtaining image results in women with echocardi-
ography or radionuclide scintigraphy, this study was
designed to address the prognostic utility of
DCMR in women.
The women enrolled in this study exhibited an
average age similar to those referred for cardiovas-
cular stress testing (14). Also, they exhibited poor
acoustic windows for transthoracic echocardiogra-
phy. As shown in Table 1 and in Figure 1, the
proportion of women with events and the event-
free survival of those women with and without
DCMR-inducible LVWM abnormalities during
testing is similar to populations previously reported
undergoing DCMR noninvasive cardiac stress test-
ing that predominately included men (1,2). Women
without inducible LVWM abnormalities during
testing experienced a favorable prognosis for the 5
years after testing. The post-stress proportion of
women with events of 1.2% per year is similar to
that reported in previous DCMR stress testing
comprised primarily of men (1,2). Also, as shown in
Table 2, the hemodynamic response to cardiovas-
cular stress is similar to that reported previously in
individuals undergoing DCMR stress testing (4). In
addition, the prognosis of women undergoing
DCMR stress testing in our study compares simi-
larly to that of other large prognostic studies of
DSE and radionuclide scintigraphy of women in
whom imaging results could be obtained (14,20).
Well-established, existing risk factors for cardiac
events, such as previous MI, diabetes, hyperlipid-
emia, and hypertension were prevalent in the
women participating in this study and were notably
disproportionally distributed between women with
and without inducible LVWM abnormalities and
cardiac events. To address whether the presence of
risk factors in the 2 study groups influenced our
results, we performed multivariable regression anal-
ysis to determine the prognostic utility of DCMR
stress results after accounting for the presence of
these risk factors. After this multivariable analysis
(Fig. 2), inducible LVWM abnormalities identified
during DCMR independently predicted future car-
diac events in women.
Given the challenge of managing women with
suspected, but not known, coronary atherosclerosis,
we performed a separate analysis to assess the utility
of DCMR in this population. Given the lower
prevalence of ischemic heart disease in women
without known coronary arteriosclerosis, there were
less cardiac events appreciated overall. Among the d110 women, only 9 hard events occurred: 5 of the
hard events occurred in the 20 women with induc-
ible ischemia. For this reason, the results of this
study indicate a trend (p  0.14) toward the utility
f DCMR wall motion results predicting future MI
nd cardiac death in women without known coro-
ary arteriosclerosis. We were able to determine
owever, that inducible ischemia is an adverse
redictor of all cardiac events. These results dem-
nstrate that the identification of a DCMR induced
VWM abnormality provides additional prognostic
nformation for identifying cardiac risk in women
ith known or suspected ischemic heart disease.
Previous studies of cardiac prognosis after
CMR stress have demonstrated a trend toward an
ssociation between the number of LV myocardial
egments with inducible ischemia and more fre-
uent adverse events (1,21,22). Our results in
omen demonstrate a similar trend. However, as a
afety precaution we note that our stress testing
rotocol was terminated at the earliest detection of
wall motion abnormality, thus potentially limiting
ur ability to identify all myocardial regions at risk
4). A study with more participants may discern the
elationship between number of LV myocardial
egments with inducible LVWM abnormalities and
ncremental cardiac risk in women.
Two important aspects of the study population
erit further discussion. First, as shown in Table 1,
he average BMI of the participants enrolled in this
tudy was elevated (classified as obese by the World
ealth Organization) (23). Obesity is increasing in
revalence in many developing and developed in-
ustrialized nations (23). Likely, the elevated BMI
ccounts for the reason why many of the women
ere referred after failed DSE because of poor
coustic windows. High spatial and temporal reso-
ution images are acquired during DCMR that
llow for early recognition of inducible LVWM
bnormalities (4,5). In this study, all myocardial
egments were visualized throughout the course of
CMR testing. The results of this study indicate
hat in relatively obese women DCMR is a suitable
esting modality for accurately identifying cardiac
isk.
Second, the LVEF in this particular study aver-
ged 59  11%. This result is not surprising given
hat many elderly women with cardiac disorders
uch as heart failure exhibit a preserved LVEF
24,25). Recently, our group identified that the
resence of inducible LVWM abnormalities during
obutamine stress in patients with a LVEF 40%
id not offer prognostic information above and
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306beyond the resting LVEF (26). In this study, only
14 participants exhibited a resting LVEF 40%. It
is important to recognize that data from the current
study indicate that the presence of DCMR induc-
ible LVWM abnormalities is predictive of adverse
cardiac events in women whom the majority exhibit
a LVEF 40%. We remain uncertain as to the
prognostic utility of dobutamine inducible LVWM
abnormalities in women with a LVEF 40%.
Study limitations. Our study has the following lim-
itations. First, our study used visual assessments of
LVWM. Newer imaging protocols that involve
simultaneous assessments of LVWM, myocardial
perfusion, and late gadolinium enhancement may
yield improved results in certain patient populations
(27). Second, we are uncertain of the prevalence of
LV hypertrophy in our participants. LV hypertro-
phy is a known predictor of adverse cardiac eventsof the Council on Clinical Cardiology
1
1
1
1
41–6.C O N C L U S I O N S
Inducible ischemia of any myocardial segment dur-
ing DCMR predicts cardiac death and MI in
women, whereas women with no evidence of isch-
emia have a good mid-term prognosis. Thus,
DCMR is a suitable noninvasive stress imaging
modality for identifying cardiac risk in women that
may be at risk for adverse cardiac events, and
DCMR stress results exhibit high prognostic utility
similar to that previously identified in men.
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